Treating smokers before the quit date: Can nicotine patches and denicotinized cigarettes reduce cravings?

被引:25
作者
Rezaishiraz, Hamed [1 ]
Hyland, Andrew [1 ]
Mahoney, Martin C. [1 ]
O'Connor, Richard J. [1 ]
Cummings, K. Michael [1 ]
机构
[1] Roswell Pk Canc Inst, Dept Hlth Behav, Buffalo, NY 14263 USA
关键词
D O I
10.1080/14622200701684172
中图分类号
R194 [卫生标准、卫生检查、医药管理];
学科分类号
摘要
The present study investigated whether treatment with the combination of denicotinized cigarettes and 21-mg nicotine patch for 2 weeks before a designated quit date could lessen cravings for smoking, thereby helping smokers abstain from smoking. The study was a randomized controlled clinical trial conducted at Roswell Park Cancer Institute, Buffalo, New York, in 2004 and 2005. Patients included 98 adult heavy smokers (using 20 or more cigarettes/day). Half of the subjects received 2 weeks of combination of denicotinized cigarettes (Quest 3) and 21-mg nicotine patch for 2 weeks before the quit date. The remaining smokers were switched to light cigarettes (Quest 1) during the 2 weeks before the quit date. After the quit date, all subjects received counseling for smoking cessation and were provided nicotine patches for up to 8 weeks after the quit date. Self-reported cravings for smoking, withdrawal symptoms, and smoking abstinence were measured at predetermined intervals using phone-based surveys and in clinical visits. The group that used denicotinized cigarettes and nicotine patch before quitting reported less frequent and less intense cravings for cigarettes in the 2 weeks before and after the designated quit date. Self-reported withdrawal symptoms and quit rates did not differ significantly between the groups. The use of a denicotinized cigarette combined with the nicotine patch appears to lessen cravings to smoke in the immediate postcessation period. A larger, better-powered study is needed to test if this treatment combination has merit for increasing quit rates.
引用
收藏
页码:1139 / 1146
页数:8
相关论文
共 24 条
[1]  
Buchhalter A R, 2001, Nicotine Tob Res, V3, P111
[2]   Tobacco abstinence symptom suppression: the role played by the smoking-related stimuli that are delivered by denicotinized cigarettes [J].
Buchhalter, AR ;
Acosta, MC ;
Evans, SE ;
Breland, AB ;
Eissenberg, T .
ADDICTION, 2005, 100 (04) :550-559
[3]   SMOKING WITHOUT NICOTINE DELIVERY DECREASES WITHDRAWAL IN 12-HOUR ABSTINENT SMOKERS [J].
BUTSCHKY, MF ;
BAILEY, D ;
HENNINGFIELD, JE ;
PICKWORTH, WB .
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 1995, 50 (01) :91-96
[4]   Applying extinction research and theory to cue-exposure addiction treatments [J].
Conklin, CA ;
Tiffany, ST .
ADDICTION, 2002, 97 (02) :155-167
[5]   CIRCUMSTANCES SURROUNDING RELAPSE IN A GROUP OF RECENT EX-SMOKERS [J].
CUMMINGS, KM ;
JAEN, CR ;
GIOVINO, G .
PREVENTIVE MEDICINE, 1985, 14 (02) :195-202
[6]   Ventral striatum/nucleus accumbens activation to smoking-related pictorial cues in smokers and nonsmokers:: A functional magnetic resonance imaging study [J].
David, SP ;
Munafò, MR ;
Johansen-Berg, H ;
Smith, SM ;
Rogers, RD ;
Matthews, PM ;
Walton, RT .
BIOLOGICAL PSYCHIATRY, 2005, 58 (06) :488-494
[7]   Activation in mesolimbic and visuospatial neural circuits elicited by smoking cues: Evidence from functional magnetic resonance imaging [J].
Due, DL ;
Huettel, SA ;
Hall, WG ;
Rubin, DC .
AMERICAN JOURNAL OF PSYCHIATRY, 2002, 159 (06) :954-960
[8]  
Fiore MC., 2000, TREATING TOBACCO USE
[9]   Varenicline, an α4β2 nicotinic acetylcholine receptor partial agonist, vs sustained-release bupropion and placebo for smoking cessation -: A randomized controlled trial [J].
Gonzales, David ;
Rennard, Stephen I. ;
Nides, Mitchell ;
Oncken, Cheryl ;
Azoulay, Salomon ;
Billing, Clare B. ;
Watsky, Eric J. ;
Gong, Jason ;
Williams, Kathryn E. ;
Reeves, Karen R. .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2006, 296 (01) :47-55
[10]   Nicotine-containing versus de-nicotinized cigarettes: Effects on craving and withdrawal [J].
Gross, J ;
Lee, J ;
Stitzer, ML .
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 1997, 57 (1-2) :159-165